Nanoparticle delivery of TFOs is a novel targeted therapy for HER2 amplified breast cancer

PURPOSE: The human EGFR2 (HER2) signaling pathway is one of the most actively studied targets in cancer transformation research. Ttriplex-forming oligonucleotides (TFOs) activate DNA damage and induce apoptosis. We aim to encapsulate TFO-HER2 with nano-particle ZW-128 to suppress breast cell growth...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiaojing, Xu, Yi, Fu, Jie, Shen, Zan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357592/
https://www.ncbi.nlm.nih.gov/pubmed/37468837
http://dx.doi.org/10.1186/s12885-023-11176-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357592/
https://www.ncbi.nlm.nih.gov/pubmed/37468837
http://dx.doi.org/10.1186/s12885-023-11176-8

Ejemplares similares